# Peptides Source Review 2026: 137-Product Catalog, Aggressive GLP-1 Pricing, and Research-First Quality Claims
Disclaimer: All compounds mentioned in this article are intended strictly for laboratory research purposes. They are not approved for human use. This content is educational only and does not constitute medical advice.
---
Peptides Source enters the research peptide market with a clear value proposition: high-purity research compounds at accessible prices, with the largest GLP-1 agonist selection of any supplier indexed on Peptides.SO's platform at 17 listings. Their 137-product catalog covers the core peptide categories with competitive pricing that consistently undercuts many established US suppliers, particularly on growth peptides and healing compounds.
This review is based on product and pricing data from Peptides Source as indexed on Peptides.SO, along with publicly available quality documentation.
---
Company Background & Positioning
Peptides Source (peptidessource.com) positions itself around a quality-first message: "finest quality peptides... purity, potency, and precision... meticulously sourced and rigorously tested." All products are explicitly labeled for laboratory research use only, not for human or animal consumption.
Key characteristics:
- •137 active listings — mid-large catalog with strong category coverage
- •17 GLP-1 agonist listings — the highest GLP-1 selection of any supplier indexed on our platform
- •Competitive pricing — among the most affordable across growth, healing, and weight management categories
- •Stringent quality control messaging — publicly commits to rigorous testing standards
The supplier's catalog reflects a research-forward philosophy: broad compound availability, moderate pricing, and a commitment to legitimate research-only positioning. Their GLP-1 depth is particularly notable given the current surge in semaglutide, tirzepatide, and related compound research interest.
---
Product Catalog Breadth
Peptides Source carries 137 listings across 12 categories:
| Category | Listings | Price Range |
|---|---|---|
| Growth peptides | 38 | $20–$350 |
| Healing & recovery | 25 | $35–$270 |
| GLP-1 agonists | 17 | $30–$400 |
| Weight management | 14 | $35–$190 |
| Anti-aging | 8 | $25–$100 |
| Cognitive | 8 | $30–$140 |
| Sexual health | 10 | $15–$60 |
| Immune support | 4 | $55–$110 |
| Research peptides | 6 | $40–$150 |
| SARMs & compounds | 3 | $70–$120 |
| Supplies & accessories | 3 | $25–$35 |
| Cosmetic peptides | 1 | $60 |
GLP-1 standout: Peptides Source's 17 GLP-1 agonist listings — averaging $154/unit with a range of $30–$400 — are the most comprehensive GLP-1 selection indexed on our platform. This includes multiple Semaglutide variants, Tirzepatide (dual GIP/GLP-1), Liraglutide, and related analogs across different concentrations and vial sizes. For researchers studying metabolic diseases, appetite regulation, or novel GLP-1 receptor agonists, this breadth is a significant advantage.
Growth peptide dominance: 38 growth peptide listings is one of the higher counts among indexed suppliers. The category spans standard GHRP compounds (GHRP-2, GHRP-6, Ipamorelin), modified GRF analogs (CJC-1295 No DAC, CJC-1295 DAC), Sermorelin, Tesamorelin, IGF-1 variants, and growth factor compounds including Follistatin and Mechano Growth Factor.
Notable catalog highlights:
- •BPC-157 — multiple vial sizes, entry pricing from $35 | Core healing peptide at competitive entry price point
- •TB-500 (Thymosin Beta-4) — healing/recovery category, multiple sizes
- •Semaglutide — $30–$400 | Available across a broad dosing spectrum
- •Tirzepatide — dual GIP/GLP-1 agonist at competitive pricing for the compound class
- •CJC-1295 No DAC + Ipamorelin blend — growth peptide research stack
- •Sermorelin — cognitive and growth overlap compound
- •Sexual health compounds — 10 listings from $15/entry | Broadest affordable sexual health selection indexed on our platform
- •Selank — $30 | Significantly below market average for this cognitive/anxiolytic peptide
- •Semax — $30 | Similarly priced below market for ACTH analog
Price leadership in key categories: Peptides Source's pricing on sexual health compounds ($15–$60) and cognitive compounds ($30–$140) is among the most accessible of any supplier indexed on our platform. At $15 for entry-tier sexual health compounds, the barrier to research-grade access is meaningfully lower.
---
Pricing Analysis
Peptides Source is a clear price leader in the research peptide market for most compound categories. Researchers who prioritize accessible pricing for standard compounds will find consistent value here.
Key pricing benchmarks vs. platform competitors:
| Peptide | Peptides Source | Swiss Chems | Iron Mountain Labz | Biotech Peptides |
|---|---|---|---|---|
| BPC-157 entry | ~$35 | ~$50 | ~$54 | $52 |
| TB-500 entry | ~$40 | ~$45 | ~$49 | $72 |
| CJC-1295 No DAC | ~$25 | ~$35 | ~$42 | $46 |
| Semaglutide entry | ~$30 | ~$70 | ~$80 | — |
| Selank | ~$30 | ~$26 | ~$35 | $46 |
| Sexual health avg | ~$37 | ~$45 | ~$50 | ~$55 |
Peptides Source consistently prices 15–40% below the mid-tier market for commodity peptides. This pricing model suggests either a leaner cost structure, higher volume, or different margin expectations — all of which can benefit researchers on restricted budgets.
GLP-1 pricing advantage: At an average of $154/unit for GLP-1 compounds with entry pricing from $30, Peptides Source is among the most affordable indexed sources for semaglutide and tirzepatide research compounds. Competing suppliers typically price these compounds $50–$100 higher at the entry tier.
Discount programs: No publicly listed discount code in current platform data.
---
Testing & Quality Standards
Peptides Source publicly commits to a stringent quality program:
- •"Meticulous sourcing and rigorous testing" — stated quality control framework
- •"Stringent quality control measures to guarantee efficacy and safety" — purity and potency standards
- •Research-only positioning with clear non-human use disclaimers
- •Purity, potency, and precision as stated product standards
The quality messaging is consistent with industry-standard research peptide positioning. However, specific elements that sophisticated researchers look for — publicly accessible COAs, explicit purity percentages, named third-party testing labs, endotoxin data — are not confirmed from publicly available documentation at time of review.
What to request before ordering:
- •Batch-specific COA with HPLC purity percentage
- •Third-party lab name and test date
- •Endotoxin data if ordering for cell culture applications
No platform verification status on Peptides.SO at time of review.
---
Customer Reviews: Platform Analysis
Peptides Source has 0 verified platform reviews on Peptides.SO at time of this review. For a supplier with competitive pricing and broad catalog depth, the absence of platform reviews reflects early indexing stage rather than market absence.
The supplier's accessibility pricing model — particularly for GLP-1 compounds and growth peptides — suggests a volume-oriented business positioned to attract research buyers seeking cost-effective sourcing. Community forum discussions and independent verification should complement platform data for due diligence on initial orders.
---
Shipping, Payment & Returns
Based on publicly available information:
- •US-facing operations: Site targets US research community; shipping details confirmed through direct contact
- •Research-only sale: Explicit non-human use disclaimers throughout
- •Supplies included: 3 accessory listings available for reconstitution and research support
- •Returns/guarantees: Contact supplier directly for current policies
---
Catalog Comparison: GLP-1 and Growth Peptide Leaders
| Supplier | Total Listings | GLP-1 Listings | Growth Peptides | Healing & Recovery |
|---|---|---|---|---|
| Peptides Source | 137 | 17 | 38 | 25 |
| Iron Mountain Labz | ~409 | ~8 | ~60 | ~35 |
| PureRawz | ~356 | ~10 | ~50 | ~30 |
| Genetic Peptide | 154 | 9 | 28 | 21 |
| Swiss Chems | ~148 | ~6 | ~30 | ~20 |
| Biotech Peptides | 97 | 0 | 35 | 9 |
Peptides Source leads all indexed suppliers in GLP-1 agonist listings and ranks near the top for growth peptides by count. Combined with the most affordable average pricing in these categories, this positions them as the primary research destination for researchers whose work centers on metabolic or growth hormone pathways.
---
Bottom Line: Who Should Use Peptides Source?
Best choice for:
- •GLP-1 research — the deepest semaglutide/tirzepatide/liraglutide selection indexed on our platform
- •Budget-conscious researchers needing broad compound coverage
- •Growth peptide protocols requiring multiple GHRH/GHRP variants
- •Sexual health research with the most accessible entry-tier pricing on the platform
Consider alternatives for:
- •Pre-verified COAs accessible online — request directly from supplier
- •Endotoxin-free compounds for cell culture — Pure Tested Peptides or CPC Scientific
- •Cosmetic peptides — Biotech Peptides has far deeper cosmetic selection (18 vs. 1 listing)
- •Bioregulators — BioLongevity Labs or Ruo Bio for deeper bioregulator coverage
Peptides Source stands out on two dimensions: GLP-1 catalog depth and competitive pricing across core research categories. Researchers who need the broadest selection of weight management and metabolic research compounds at the most accessible price points have a compelling primary source in Peptides Source.
---
Data sourced from Peptides.SO platform listings and publicly available supplier documentation. Pricing reflects indexed data at time of publication and may vary. All compounds are for research use only.